Finally, we made a prediction model based on SLC35C1 expression and clinical symptoms to predict the prognosis of glioma, and further constructed its regulatory mechanism in glioma progression, and confirmed that SLC35C1 was highly expressed in glioma. This evidence concerns the gene SLC35C1 and central nervous system cancer.